Janus nanoparticles: from fabrication to (Bio)applications
Angina pectoris Angina pectoris is chest pain that occurs when the coronary blood supply is insufficient to meet the metabolic needs of the heart muscle (as with ischemic heart disease
At 56 weeks, the change in body weight was 8% in the liraglutide group and 2.5% in the placebo group, and 63.2% participants in the liraglutide group achieved weight loss of 5% or greater compared with 27.1% of the placebo groups
Carbohydrate12 g/0.48 g, of which sugars 0 g/0 g, of which polyols 9 g/0.36 g);Protein 0 g/0 g
Prioritize Sleep: Quality sleep is vital for recovery and overall health, helping to regulate hormones that influence weight
Shared decision-making between patient and provider should guide therapeutic adjustments, balancing metabolic benefits against tolerability concerns